See also this year's filing and all EDGAR filings for this company.
PDF Report 0001557746_2023_Aclaris_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001557746, Aclaris Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 231,550,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 6,973,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,099,000 |
| 3 | remainder_Assets | 14,974,000 |
| 4 | LiabilitiesCurrent | 21,938,000 |
| 5 | LiabilitiesNoncurrent | 1,570,000 |
| 6 | remainder_Liabilities | 33,467,000 |
| 7 | CostOfGoodsAndServicesSold | 4,023,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 25,133,000 |
| 9 | ResearchAndDevelopmentExpense | 77,813,000 |
| 10 | remainder_Expenses | 12,637,000 |
| 11 | remainder_Revenues | 29,752,000 |
| 12 | remainder_NetIncome | 2,946,000 |
| 13 | remainder_ComprehensiveNetIncome | -673,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 254,596,000 |
| 1 | Liabilities | 56,975,000 |
| 2 | Expenses | 119,606,000 |
| 3 | Revenues | 29,752,000 |
| 4 | StockholdersEquity | 197,621,000 |
| 5 | NetIncome | -86,908,000 |
| 6 | ComprehensiveNetIncome | -87,244,500 |
| 7 | BaseVar | 232,274,000 |
| 8 | EconomicCapitalRatio | 1.62 |
Edgar->Model Mapping
Feature Distribution
Change over Time
